[Research progress on the role and mechanism of PANoptosis in lung diseases]

  • 0Department of Anesthesiology, Tianjin Union Medical Center (the First Affiliated Hospital of Nankai University), Tianjin 300121, China. Corresponding author: Xu Jiangang,

|

|

Summary

This summary is machine-generated.

PANoptosis, a programmed cell death form, is linked to lung diseases like ALI/ARDS. Understanding its mechanisms may reveal new therapeutic targets for these conditions.

Area Of Science

  • Immunology
  • Cell Biology
  • Pathology

Background

  • Programmed cell death (PCD) is vital for pathogen defense but over-activation can worsen inflammation and tissue damage.
  • PANoptosis, a newly identified PCD, integrates apoptosis, pyroptosis, and necroptosis.
  • PANoptosis is implicated in the pathogenesis of lung diseases including acute lung injury/acute respiratory distress syndrome (ALI/ARDS), asthma, and chronic obstructive pulmonary disease (COPD).

Purpose Of The Study

  • To review the molecular mechanisms of PANoptosis.
  • To explore regulatory factors of PANoptosis in the context of lung diseases.
  • To identify potential therapeutic targets for lung diseases based on PANoptosis pathways.

Main Methods

  • Literature review of studies on PANoptosis.
  • Analysis of molecular pathways involved in PANoptosis.
  • Examination of the role of PANoptosis in various lung diseases.

Main Results

  • PANoptosis is a complex cell death pathway with significant implications in lung disease development.
  • Specific molecular mechanisms and regulatory factors of PANoptosis in lung diseases have been identified.
  • The dysregulation of PANoptosis contributes to the progression of ALI/ARDS, asthma, and COPD.

Conclusions

  • PANoptosis represents a crucial cellular process in lung pathophysiology.
  • Targeting PANoptosis pathways offers promising therapeutic strategies for lung diseases.
  • Further research into PANoptosis could lead to innovative treatments for respiratory conditions.